Vitality Watch

Dossier clinicaltrials observational 14-jul-2026
Human cohort, case-control, or epidemiological association

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Key claim: A prospective observational study is assessing sarcopenia and sarcopenic obesity prevalence in people with metabolic and endocrine diseases and whether myokines act as biomarkers or drivers of these conditions.

Abstract

Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population.

.

Why this matters

A prospective observational study is assessing sarcopenia and sarcopenic obesity prevalence in people with metabolic and endocrine diseases and whether myokines act as biomarkers or drivers of these conditions.

Source

Link

Briefing card

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
Stage: observational · clinicaltrials · 14-jul-2026

A prospective observational study is assessing sarcopenia and sarcopenic obesity prevalence in people with metabolic and endocrine diseases and whether myokines act as biomarkers or drivers of these conditions.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07703683

build build 880 · 2bcef25 · 2026-11-18